Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avidity Biosciences Inc shares valued at $163,486 were sold by Gallagher Kathleen P. on Apr 01 ’25. At $27.83 per share, Gallagher Kathleen P. sold 5,875 shares. The insider’s holdings dropped to 50,554 shares worth approximately $1.22 million following the completion of this transaction.
Also, Hughes Steven George sold 9,578 shares, netting a total of over 297,491 in proceeds. Following the sale of shares at $31.06 each, the insider now holds 72,850 shares.
Before that, Boyce Sarah had sold 31,540 shares from its account. In a trade valued at $979,563, the President and CEO traded Avidity Biosciences Inc shares for $31.06 each. Upon closing the transaction, the insider’s holdings decreased to 31,540 shares, worth approximately $7.37 million.
As published in their initiating research note from Citigroup on March 13, 2025, Avidity Biosciences Inc [RNA] has been a Buy and the price target has been revised to $70. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid March. As of March 07, 2025, Scotiabank has initiated its “Sector outperform” rating for RNA. Earlier on December 20, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for RNA stock.
Analyzing RNA Stock Performance
During the last five days, there has been a drop of approximately -14.20%. Over the course of the year, Avidity Biosciences Inc shares have dropped approximately -17.09%. Shares of the company reached a 52-week high of $36.38 on 03/13/25 and a 52-week low of $21.51 on 04/09/25. A 50-day SMA is recorded $30.79, while a 200-day SMA reached $38.45.
Support And Resistance Levels for Avidity Biosciences Inc (RNA)
According to the 24-hour chart, there is a support level at 23.38, which, if violated, would cause prices to drop to 22.64. In the upper region, resistance lies at 24.67. The next price resistance is at 25.22. RSI (Relative Strength Index) is 35.60 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.30, which suggests the price will decrease in the coming days. Percent R is at 78.83%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
